Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference14 articles.
1. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study;Yang;Lancet Respir Med,2020
2. Effect of a low vs intermediate tidal volume strategy on ventilator-free days in intensive care unit patients without ARDS: a randomized clinical trial;Simonis;JAMA,2018
3. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2);Yao;Clin Infect Dis,2020
4. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro;Liu;Cell Discov,2020
5. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;Wang;Cell Res,2020
Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Medical care for SARS-CoV-2;Stem Cells;2024
2. Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications;Pharmacogenomics;2023-10
3. Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics;Molecular Aspects of Medicine;2023-06
4. Zinc augments the antiviral potential of HCQ/CQ and ivermectin to reduce the risks of more serious outcomes from COVID-19 infection;Journal of Trace Elements in Medicine and Biology;2022-05
5. Healthcare Management Intricacy, Governance, and Strategic Plan During the COVID-19 Pandemic (With Special Reference to India);Advances in Medical Technologies and Clinical Practice;2022-04-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3